NorthWest Biotherapeutics Inc (NWBO)

[WideEyed]

Beartrap,

I agree with you. The markets are forward looking. There are many people with a lot invested here. Initially, many people will want to sell a little; after that the institutions/funds will take over buying. Sawston capacity is just over $2 billion in revenue per year. Six months out full capacity revenue for Sawston would be $1 billion; think the analysts will give us $500 million out of the gate. Using a 20x multiplier because we’re an exciting new biotech, NWBO stock price = ($500 X 20x) / 1.5 billion shares = $6.66 per share soon after approval. Add in $ from Franchises/Partnerships and we’re over $10 soon after approval.